Institutional Ownership Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the institutional ownership of Terns Pharmaceuticals, Inc. (TERN). We have compiled data on the 157 institutions that hold shares in the stock, with a total of 84.1 Million shares, which have been reported (via 13F filing form) to have a value of $194 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Decheng Capital Management Iii (Cayman), LLC
|
Nov 13, 2023 Q3 2023 |
714,285
shares
|
$1.71 Million
1.99% of portfolio
|
Q1 2022
New holding
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
704,371
shares
|
$1.69 Million
0.0% of portfolio
|
Q4 2024
Added 642.21%
|
|
|
Russell Investments Group, Ltd.
|
Feb 13, 2025 Q4 2024 |
628,395
shares
|
$1.51 Million
0.01% of portfolio
|
Q4 2024
Reduced 15.62%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
623,134
shares
|
$1.5 Million
0.01% of portfolio
|
Q4 2024
Added 29.95%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
591,171
shares
|
$1.42 Million
0.0% of portfolio
|
Q4 2024
Added 27.44%
|
|
|
Altium Capital Management LP
New York, NY |
Feb 13, 2025 Q4 2024 |
475,000
shares
|
$1.14 Million
0.88% of portfolio
|
Q4 2024
Added 43.94%
|
|
|
Integral Health Asset Management, LLC
|
Feb 14, 2025 Q4 2024 |
450,000
shares
|
$1.08 Million
0.22% of portfolio
|
Q4 2024
Added 50.0%
|
|
|
Acuta Capital Partners, LLC
Belmont, CA |
Feb 14, 2025 Q4 2024 |
447,500
shares
|
$1.07 Million
3.55% of portfolio
|
Q4 2024
Reduced 8.11%
|
|
|
Sg Americas Securities, LLC
|
Apr 15, 2025 Q1 2025 |
413,822
shares
|
$993,172
0.0% of portfolio
|
Q1 2025
Added 1141.48%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
401,658
shares
|
$963,979
0.0% of portfolio
|
Q4 2024
Added 478.77%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
398,379
shares
|
$956,109
0.0% of portfolio
|
Q4 2024
Reduced 26.61%
|
|
|
Alliancebernstein L.P.
New York, NY |
Feb 12, 2025 Q4 2024 |
362,359
shares
|
$869,661
0.0% of portfolio
|
Q4 2024
Added 48.16%
|
|
|
Salem Investment Counselors Inc
Winston Salem, NC |
Apr 16, 2025 Q1 2025 |
346,850
shares
|
$832,440
0.03% of portfolio
|
Q1 2025
Added 0.04%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
343,050
shares
|
$823,320
0.0% of portfolio
|
Q4 2024
Reduced 18.1%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
314,389
shares
|
$754,533
0.0% of portfolio
|
Q4 2024
Reduced 31.2%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
311,612
shares
|
$747,868
0.01% of portfolio
|
Q4 2024
Added 3.45%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
308,491
shares
|
$740,378
0.28% of portfolio
|
Q4 2024
Reduced -0.0%
|
|
|
Trexquant Investment LP
Stamford, CT |
Feb 12, 2025 Q4 2024 |
253,247
shares
|
$607,792
0.02% of portfolio
|
Q4 2024
Reduced 16.67%
|
|
|
Lpl Financial LLC
Fort Mill, SC |
Feb 11, 2025 Q4 2024 |
252,325
shares
|
$605,580
0.0% of portfolio
|
Q4 2024
Added 397.19%
|
|
|
J. Goldman & CO LP
New York, NY |
Feb 14, 2025 Q4 2024 |
235,831
shares
|
$565,994
0.04% of portfolio
|
Q4 2024
Added 15.64%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
206,450
shares
|
$495,480
0.0% of portfolio
|
Q4 2024
Added 33.44%
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
202,348
shares
|
$485,635
0.35% of portfolio
|
Q1 2023
New holding
|
|
|
Infinitum Asset Management, LLC
Fort Lauderdale, FL |
Feb 25, 2025 Q4 2024 |
200,000
shares
|
$480,000
0.59% of portfolio
|
Q4 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
197,226
shares
|
$473,342
0.0% of portfolio
|
Q4 2024
Added 236.76%
|
|
|
Polymer Capital Management (Hk) LTD
Hong Kong, K3 |
Feb 13, 2025 Q4 2024 |
177,000
shares
|
$424,800
0.17% of portfolio
|
Q4 2024
Added 637.5%
|